NasdaqGM - Delayed Quote USD

Cerus Corporation (CERS)

Compare
1.6800 +0.0100 (+0.60%)
At close: November 19 at 4:00 PM EST
1.6900 +0.01 (+0.60%)
After hours: November 19 at 4:32 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
176,229.0000
156,367.0000
162,048.0000
130,859.0000
91,920.0000
Cost of Revenue
78,133.0000
69,967.0000
74,954.0000
63,475.0000
41,157.0000
Gross Profit
98,096.0000
86,400.0000
87,094.0000
67,384.0000
50,763.0000
Operating Expense
109,896.0000
112,725.0000
121,175.0000
116,320.0000
109,096.0000
Operating Income
-11,800.0000
-26,325.0000
-34,081.0000
-48,936.0000
-58,333.0000
Net Non Operating Interest Income Expense
-9,053.0000
-8,386.0000
-5,831.0000
-4,923.0000
-3,746.0000
Other Income Expense
1,231.0000
-2,611.0000
-2,425.0000
-198.0000
2,506.0000
Pretax Income
-19,622.0000
-37,322.0000
-42,337.0000
-54,057.0000
-59,573.0000
Tax Provision
166.0000
325.0000
488.0000
319.0000
284.0000
Net Income Common Stockholders
-19,725.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Diluted NI Available to Com Stockholders
-19,725.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Basic EPS
-0.11
-0.21
-0.24
-0.32
-0.37
Diluted EPS
-0.11
-0.21
-0.24
-0.32
-0.37
Basic Average Shares
183,435.0000
180,270.0000
176,545.0000
171,279.0000
163,949.0000
Diluted Average Shares
185,626.0000
180,270.0000
176,545.0000
171,279.0000
163,949.0000
Total Operating Income as Reported
-11,800.0000
-30,053.0000
-34,081.0000
-48,936.0000
-58,333.0000
Total Expenses
188,029.0000
182,692.0000
196,129.0000
179,795.0000
150,253.0000
Net Income from Continuing & Discontinued Operation
-19,725.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Normalized Income
-19,059.0300
-34,031.9600
-42,233.9000
-53,956.4400
-60,435.8900
Interest Expense
9,053.0000
8,386.0000
5,831.0000
4,923.0000
3,746.0000
Net Interest Income
-9,053.0000
-8,386.0000
-5,831.0000
-4,923.0000
-3,746.0000
EBIT
-10,569.0000
-28,936.0000
-36,506.0000
-49,134.0000
-55,827.0000
EBITDA
-8,399.0000
-26,337.0000
-33,522.0000
-45,986.0000
-52,718.0000
Reconciled Cost of Revenue
78,133.0000
69,967.0000
74,954.0000
63,475.0000
41,157.0000
Reconciled Depreciation
2,170.0000
2,599.0000
2,984.0000
3,148.0000
3,109.0000
Net Income from Continuing Operation Net Minority Interest
-19,725.0000
-37,489.0000
-42,779.0000
-54,374.0000
-59,857.0000
Total Unusual Items Excluding Goodwill
-843.0000
-4,376.0000
-690.0000
-572.0000
793.0000
Total Unusual Items
-843.0000
-4,376.0000
-690.0000
-572.0000
793.0000
Normalized EBITDA
-7,556.0000
-21,961.0000
-32,832.0000
-45,414.0000
-53,511.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-177.0300
-918.9600
-144.9000
-154.4400
214.1100
12/31/2020 - 1/31/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PACB Pacific Biosciences of California, Inc.
1.7200
+9.55%
 
MASS 908 Devices Inc.
2.4800
+5.08%
 
QSI Quantum-Si incorporated
0.6330
-4.22%
 
LAB Standard BioTools Inc.
1.5100
+0.67%
 
BFLY Butterfly Network, Inc.
3.0500
+15.53%
 
BVS Bioventus Inc.
11.59
+3.02%
 
XAIR Beyond Air, Inc.
0.5246
+3.11%
 
AXGN Axogen, Inc.
12.75
-0.39%
 
ECOR electroCore, Inc.
10.09
+4.56%
 
DCTH Delcath Systems, Inc.
9.91
+1.75%